Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor

Molecular and Cellular Endocrinology
Carlotta GaunaAart Jan van der Lely

Abstract

Both unacylated ghrelin (UAG) and acylated ghrelin (AG) exert metabolic effects. To investigate the interactions between AG and UAG on ghrelin receptors we evaluated the effects of AG and UAG on INS-1E rat insulinoma cells, using insulin secretion after 30min static incubation as a read-out. A possible involvement of the growth hormone secretagogue receptor type 1a (GHS-R1a) or the corticotropin-releasing factor 2 (CRF2) receptor (CRF2R), as a putative receptor for UAG, was also studied determining their mRNA expression and the functional effects of receptor antagonists on insulin release. Both UAG and AG stimulated insulin release dose-dependently in the nanomolar range. The AG-induced insulin output was antagonized by two GHS-R1a antagonists ([d-Lys(3)]GHRP-6 and BIM28163), which did not block UAG actions. These effects occurred in the presence of low levels of GHS-R1a mRNA. Neither CRF2R expression nor effects of the CRF2R antagonist (astressin(2)B) on insulin output were observed. In conclusion, we provide a sensitive and reproducible assay for specific effects of UAG, which in this study is responsible for insulin release by INS-1E cells. Our data support the existence of a specific receptor for UAG, other than the CRF2R a...Continue Reading

References

Apr 12, 2001·The Journal of Clinical Endocrinology and Metabolism·C Y Bowers
Apr 21, 2001·Journal of Endocrinological Investigation·G MuccioliR Deghenghi
Oct 16, 2001·The Journal of Clinical Endocrinology and Metabolism·F BroglioE Ghigo
Feb 9, 2002·European Journal of Endocrinology·E M EgidoJ Marco
Jul 18, 2002·Journal of Neuroendocrinology·E Adeghate, A S Ponery
Feb 15, 2003·Endocrinology·Martina Kvist ReimerBo Ahrén
Sep 13, 2003·European Journal of Pharmacology·Ivano BedendiGiampiero Muccioli
Feb 18, 2004·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·N WierupF Sundler
Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yuxiang SunRoy G Smith
Jun 8, 2004·Endocrine Reviews·Aart J van der LelyEzio Ghigo
Nov 6, 2004·FEBS Letters·Chi-Bun ChanChristopher H K Cheng
Nov 13, 2004·The Journal of Clinical Endocrinology and Metabolism·Carlotta GaunaAart Jan van der Lely
Apr 9, 2005·Endocrine Reviews·Roy G Smith
Jan 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Asako DoiKishio Nanjo

❮ Previous
Next ❯

Citations

Aug 27, 2011·Langenbeck's Archives of Surgery·M GassR Peterli
Sep 25, 2012·Current Gastroenterology Reports·Andreas Stengel, Yvette Taché
Jul 16, 2011·Hormones & Cancer·Jenny N T FungChen Chen
Sep 26, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Petra WiedmerMatthias H Tschöp
Aug 12, 2010·International Journal of Peptides·Leena PulkkinenMatti Uusitupa
Sep 14, 2007·Neuroendocrinology·Manuel Tena-Sempere
Sep 28, 2007·Neuroendocrinology·Yuxiang SunRoy G Smith
Mar 20, 2008·The Journal of Clinical Endocrinology and Metabolism·Jianhua LiuMichael O Thorner
Apr 24, 2012·Journal of Neurogastroenterology and Motility·Andreas Stengel, Yvette Taché
Mar 14, 2013·European Journal of Endocrinology·Jenny TongPankaj B Desai
Aug 18, 2012·European Journal of Endocrinology·Patric J D DelhantyAart J van der Lely
May 28, 2011·Molecular and Cellular Endocrinology·Inge SeimLisa Chopin
Apr 15, 2011·Molecular and Cellular Endocrinology·Miski ScerifMárta Korbonits
Feb 25, 2011·Molecular and Cellular Endocrinology·Miski ScerifMárta Korbonits
Jun 30, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·H HirayamaY Shimizu
Nov 29, 2011·Regulatory Peptides·Kazunori KageyamaToshihiro Suda
Mar 15, 2011·Peptides·P J D Delhanty, A J van der Lely
Sep 1, 2014·Neurobiology of Disease·I I Stoyanova
Feb 1, 2019·American Journal of Physiology. Gastrointestinal and Liver Physiology·Karuna RasineniCarol A Casey
Mar 9, 2019·Journal of Neuroendocrinology·Sarah M GrayJenny Tong
Oct 26, 2018·Eating and Weight Disorders : EWD·Gianluca Gortan Cappellari, Rocco Barazzoni
Jul 25, 2012·Endocrine Reviews·Lisa K ChopinAdrian C Herington
Mar 1, 2007·Expert Review of Endocrinology & Metabolism·M Tena-SempereF F Casanueva
Jun 13, 2014·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Haruko HirayamaYasutake Shimizu
Feb 23, 2020·Biological Procedures Online·Juliane RötheDoreen Thor
Apr 25, 2019·International Journal of Molecular Sciences·Naoaki SakataShohta Kodama
Jun 21, 2007·American Journal of Physiology. Endocrinology and Metabolism·Carlotta GaunaAart Jan van der Lely
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.